Literature DB >> 20952392

Specific binding of red blood cells to endothelial cells is regulated by nonadsorbing macromolecules.

Yang Yang1, Stephanie Koo, Cheryl Shuyi Lin, Björn Neu.   

Abstract

Abnormal adhesion of red blood cells to the endothelium has been linked to the pathophysiology of several diseases associated with vascular disorders. Various biochemical changes, including phosphatidylserine exposure on the outer membrane of red blood cells as well as plasma protein levels, have been identified as being likely to play a key role, but the detailed interplay between plasma factors and cellular factors remains unknown. It has been proposed that the adhesion-promoting effect of plasma proteins originates from ligand interaction, but evidence substantiating this assumption is often missing. In this work, we identified an alternative pathway by demonstrating that nonadsorbing macromolecules can also have a marked impact on the adhesion efficiency of red blood cells with enhanced phosphatidylserine exposure to endothelial cells. It is concluded that this adhesion-promoting effect originates from macromolecular depletion interaction and thereby presents an alternative mechanism by which plasma proteins could regulate cell-cell interactions. These findings should thus be of potential value for a detailed understanding of the pathophysiology of diseases associated with vascular complications and might be applicable to a wide range of cell-cell interactions in plasma or plasma-like media.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20952392      PMCID: PMC3003347          DOI: 10.1074/jbc.M110.116608

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  Sickle cell disease: old discoveries, new concepts, and future promise.

Authors:  Paul S Frenette; George F Atweh
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

2.  Adhesion of sickle red cells to endothelium: myths and future directions.

Authors:  R P Hebbel
Journal:  Transfus Clin Biol       Date:  2008-05-23       Impact factor: 1.406

Review 3.  Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review.

Authors:  D Bratosin; J Mazurier; J P Tissier; J Estaquier; J J Huart; J C Ameisen; D Aminoff; J Montreuil
Journal:  Biochimie       Date:  1998-02       Impact factor: 4.079

4.  Electrophoresis of human red blood cells and platelets. Evidence for depletion of dextran.

Authors:  H Bäumler; E Donath; A Krabi; W Knippel; A Budde; H Kiesewetter
Journal:  Biorheology       Date:  1996 Jul-Oct       Impact factor: 1.875

5.  Erythrocyte adhesion is modified by alterations in cellular tonicity and volume.

Authors:  Nancy J Wandersee; Rowena C Punzalan; Michael P Rettig; Michael D Kennedy; Nicholas M Pajewski; Richard L Sabina; J Paul Scott; Philip S Low; Cheryl A Hillery
Journal:  Br J Haematol       Date:  2005-11       Impact factor: 6.998

6.  Lactadherin mediates sickle cell adhesion to vascular endothelial cells in flowing blood.

Authors:  Prasenjit Guchhait; Swapan K Dasgupta; Anhquyen Le; Sarvari Yellapragada; José A López; Perumal Thiagarajan
Journal:  Haematologica       Date:  2007-09       Impact factor: 9.941

7.  Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytes.

Authors:  B N Yamaja Setty; Suhita Gayen Betal
Journal:  Blood       Date:  2007-10-02       Impact factor: 22.113

8.  Phospholipid composition and organization in model beta-thalassemic erythrocytes.

Authors:  F A Kuypers; M A Schott; M D Scott
Journal:  Am J Hematol       Date:  1996-01       Impact factor: 10.047

9.  Phosphatidylserine-positive erythrocytes bind to immobilized and soluble thrombospondin-1 via its heparin-binding domain.

Authors:  Suhita Gayen Betal; B N Yamaja Setty
Journal:  Transl Res       Date:  2008-09-04       Impact factor: 7.012

10.  Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V.

Authors:  F A Kuypers; R A Lewis; M Hua; M A Schott; D Discher; J D Ernst; B H Lubin
Journal:  Blood       Date:  1996-02-01       Impact factor: 22.113

View more
  7 in total

Review 1.  Emerging point-of-care technologies for sickle cell disease screening and monitoring.

Authors:  Yunus Alapan; Arwa Fraiwan; Erdem Kucukal; M Noman Hasan; Ryan Ung; Myeongseop Kim; Isaac Odame; Jane A Little; Umut A Gurkan
Journal:  Expert Rev Med Devices       Date:  2016-11-22       Impact factor: 3.166

2.  Where do the platelets go? A simulation study of fully resolved blood flow through aneurysmal vessels.

Authors:  L Mountrakis; E Lorenz; A G Hoekstra
Journal:  Interface Focus       Date:  2013-04-06       Impact factor: 3.906

3.  Sodium renders endothelial cells sticky for red blood cells.

Authors:  Hans Oberleithner; Mike Wälte; Kristina Kusche-Vihrog
Journal:  Front Physiol       Date:  2015-06-30       Impact factor: 4.566

4.  Heterogeneous red blood cell adhesion and deformability in sickle cell disease.

Authors:  Yunus Alapan; Jane A Little; Umut A Gurkan
Journal:  Sci Rep       Date:  2014-11-24       Impact factor: 4.379

Review 5.  Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.

Authors:  Corlia Grobler; Siphosethu C Maphumulo; L Mireille Grobbelaar; Jhade C Bredenkamp; Gert J Laubscher; Petrus J Lourens; Janami Steenkamp; Douglas B Kell; Etheresia Pretorius
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

6.  MARTX toxin of Vibrio vulnificus induces RBC phosphatidylserine exposure that can contribute to thrombosis.

Authors:  Han Young Chung; Yiying Bian; Kyung-Min Lim; Byoung Sik Kim; Sang Ho Choi
Journal:  Nat Commun       Date:  2022-08-17       Impact factor: 17.694

7.  Red Blood Cells: Tethering, Vesiculation, and Disease in Micro-Vascular Flow.

Authors:  Robert J Asaro; Pedro Cabrales
Journal:  Diagnostics (Basel)       Date:  2021-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.